Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.26 | 2.26 |
NAV | ₹10.32 | ₹170.33 |
Fund Started | 02 Sep 2025 | 13 Oct 2005 |
Fund Size | ₹773.52 Cr | ₹1420.55 Cr |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | - | 6.59% |
3 Year | - | 18.78% |
5 Year | - | 21.35% |
1 Year
3 Year
5 Year
Equity | 86.31% | 96.69% |
Cash | 0.02% | 3.31% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Larsen & Toubro Ltd. | 9.85% |
Reliance Industries Ltd. | 8.13% |
Mahindra & Mahindra Ltd. | 7.30% |
Bajaj Finance Ltd. | 4.37% |
Tata Consultancy Services Ltd. | 4.27% |
ITC Ltd. | 2.45% |
Bajaj Auto Ltd. | 2.28% |
JSW Steel Ltd. | 2.10% |
Ultratech Cement Ltd. | 2.09% |
State Bank of India | 2.07% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.79% |
Reliance Industries Ltd. | 6.82% |
ICICI Bank Ltd. | 6.53% |
HDFC Bank Ltd. | 5.93% |
NTPC Ltd. | 4.63% |
Larsen & Toubro Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.99% |
Sun Pharmaceutical Industries Ltd. | 3.69% |
Tata Consultancy Services Ltd. | 3.01% |
Dr. Reddy's Laboratories Ltd. | 2.87% |
Name | Jitendra Sriram | Sri Sharma |
Start Date | 02 Sep 2025 | 30 Apr 2021 |
Name
Start Date
Description | The Scheme seeks to achieve long term capital appreciation by investing in equity and equity related securities of companies that are part of business conglomerates in India. The Scheme does not guarantee/indicate any returns. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 02 Sep 2025 | 13 Oct 2005 |
Description
Launch Date